NCT06483074
- Conditions
- End Stage Renal Disease on Dialysis, Peritoneal Dialysis Complication, Residual Kidney Function, +1 more
- Locations
-
- Chinese University of Hong Kong Hong Kong
Clinical trial condition
Explore clinical trials studying Sodium-glucose Cotransporter-2 Inhibitor. Study availability and eligibility vary by location and protocol.
NCT06483074